Spyre Therapeutics, Inc. (SYRE): 8-K filed Nov 3, 2026

Form type

8-K

Filing date

Nov 3, 2026

Accession number

0001636282-26-000132

Filer

Spyre Therapeutics, Inc. (CIK 1636282)